European Committee on Antimicrobial Susceptibility Testing and Clinical and Laboratory Standards Institute breakpoints-the only point that matters in candidemia?
作者信息
Fazal Farhan
机构信息
Department of Medicine and Microbiology (Infectious Disease), All India Institute of Medical Science (AIIMS), New Delhi, India.
出版信息
J Thorac Dis. 2019 May;11(Suppl 9):S1412-S1414. doi: 10.21037/jtd.2019.03.12.
Abstract
摘要
相似文献
1
European Committee on Antimicrobial Susceptibility Testing and Clinical and Laboratory Standards Institute breakpoints-the only point that matters in candidemia?欧洲抗菌药物敏感性试验委员会和临床及实验室标准协会的折点——念珠菌血症中唯一重要的点？
J Thorac Dis. 2019 May;11(Suppl 9):S1412-S1414. doi: 10.21037/jtd.2019.03.12.
2
Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.根据欧洲抗菌药物敏感性试验委员会和新的与旧的临床和实验室标准协会临床折点进行的念珠菌属菌种分布和抗真菌药敏试验：来自瑞士真菌感染网络的 6 年前瞻性念珠菌血症调查。
Clin Microbiol Infect. 2014 Jul;20(7):698-705. doi: 10.1111/1469-0691.12440. Epub 2013 Dec 12.
3
Setting Antimicrobial Susceptibility Testing Breakpoints: A Primer for Pediatric Infectious Diseases Specialists on the Clinical and Laboratory Standards Institute Approach.制定抗菌药物敏感性测试折点：临床和实验室标准研究所方法简介，供儿科传染病专家使用。
J Pediatric Infect Dis Soc. 2022 Feb 23;11(2):73-80. doi: 10.1093/jpids/piab106.
4
Interpretation of Antimicrobial Susceptibility Testing Using European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) Breakpoints: Analysis of Agreement.使用欧洲抗菌药物敏感性试验委员会（EUCAST）和临床与实验室标准协会（CLSI）折点进行抗菌药物敏感性试验的解读：一致性分析
Cureus. 2023 Mar 31;15(3):e36977. doi: 10.7759/cureus.36977. eCollection 2023 Mar.
5
Comparison of Clinical Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines for the interpretation of antibiotic susceptibility at a University teaching hospital in Nairobi, Kenya: a cross-sectional study.肯尼亚内罗毕一所大学教学医院对临床实验室标准协会和欧洲抗菌药物敏感性试验委员会抗生素敏感性解读指南的比较：一项横断面研究。
Ann Clin Microbiol Antimicrob. 2016 Apr 11;15:21. doi: 10.1186/s12941-016-0135-3.
6
The association between treatment appropriateness according to EUCAST and CLSI breakpoints and mortality among patients with candidemia: a retrospective observational study.根据 EUCAST 和 CLSI 折点判断的治疗适宜性与念珠菌血症患者死亡率之间的关联：一项回顾性观察研究。
Eur J Clin Microbiol Infect Dis. 2018 Dec;37(12):2397-2404. doi: 10.1007/s10096-018-3389-1. Epub 2018 Oct 3.
7
Evaluation by data mining techniques of fluconazole breakpoints established by the Clinical and Laboratory Standards Institute (CLSI) and comparison with those of the European Committee on Antimicrobial Susceptibility Testing (EUCAST).基于临床和实验室标准协会（CLSI）制定的氟康唑折点，运用数据挖掘技术进行评估，并与欧洲抗菌药物敏感性试验委员会（EUCAST）的折点进行比较。
Antimicrob Agents Chemother. 2010 Apr;54(4):1541-6. doi: 10.1128/AAC.01688-09. Epub 2010 Feb 1.
8
Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing Position Statements on Polymyxin B and Colistin Clinical Breakpoints.临床和实验室标准协会与抗菌药物敏感性试验欧洲委员会关于黏菌素和多黏菌素 B 临床折点的立场声明。
Clin Infect Dis. 2020 Dec 3;71(9):e523-e529. doi: 10.1093/cid/ciaa121.
9
Analysis of candidemia cases in a city hospital during the COVID-19 pandemic.新冠疫情期间某市医院念珠菌血症病例分析。
Eur Rev Med Pharmacol Sci. 2024 Mar;28(6):2558-2568. doi: 10.26355/eurrev_202403_35762.
10
Impact on Antifungal Susceptibility Patterns of Previous vs. Revised Clinical and Laboratory Standards Institute Breakpoints for Candida Species Isolated from Candidemia: Experience of Two Tertiary Care Institutions in Japan.既往与修订后的临床和实验室标准协会念珠菌血症分离念珠菌属药敏试验折点对药敏模式的影响：日本两家三级医疗机构的经验
Clin Lab. 2019 Jul 1;65(7). doi: 10.7754/Clin.Lab.2019.190110.
引用本文的文献
1
resistance in Hainan Province, China: investigating phenotypes and genotypes through whole-genome sequencing.中国海南省的耐药性：通过全基因组测序研究表型和基因型。
Front Cell Infect Microbiol. 2024 Dec 17;14:1505166. doi: 10.3389/fcimb.2024.1505166. eCollection 2024.
2
Multidrug-resistant clinical K. pneumoniae ST16, ST218, and ST283 and emergence of pandrug-resistant KPC-positive ST6434/K2 lineage in Iraq.伊拉克多药耐药临床肺炎克雷伯菌ST16、ST218和ST283以及泛耐药KPC阳性ST6434/K2谱系的出现。
Braz J Microbiol. 2024 Mar;55(1):375-382. doi: 10.1007/s42770-023-01205-w. Epub 2023 Dec 13.
3
Comparative analysis of clinical breakpoints, normalized resistance interpretation and epidemiological cut-offs in interpreting antimicrobial resistance of isolates originating from poultry in different farm types in Tanzania.坦桑尼亚不同养殖类型家禽分离株抗菌药物耐药性解读中临床断点、标准化耐药性解读及流行病学临界值的比较分析
Access Microbiol. 2023 Jul 14;5(7). doi: 10.1099/acmi.0.000540.v4. eCollection 2023.
4
A Survey of Antibiotic-Resistant Genotypes and Strain Lineages by Whole-Genome Sequencing in China.中国全基因组测序对抗生素耐药基因型和菌株谱系的调查。
Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0218821. doi: 10.1128/aac.02188-21. Epub 2022 Jun 2.
5
Docusate-Based Ionic Liquids of Anthelmintic Benzimidazoles Show Improved Pharmaceutical Processability, Lipid Solubility, and Activity against .基于双羟萘酸的驱虫苯并咪唑离子液体具有改善的药物加工性能、脂溶性和对. 的活性。
ACS Infect Dis. 2021 Sep 10;7(9):2637-2649. doi: 10.1021/acsinfecdis.1c00063. Epub 2021 Sep 1.
6
Superior X-ray Radiation Shielding Effectiveness of Biocompatible Polyaniline Reinforced with Hybrid Graphene Oxide-Iron Tungsten Nitride Flakes.氧化石墨烯-氮化铁钨混合薄片增强的生物相容性聚苯胺具有优异的X射线辐射屏蔽效能
Polymers (Basel). 2020 Jun 23;12(6):1407. doi: 10.3390/polym12061407.
本文引用的文献
1
Mortality and risk factor analysis for Candida blood stream infection: A multicenter study.念珠菌血流感染的死亡率及危险因素分析：一项多中心研究。
J Infect Chemother. 2019 May;25(5):341-345. doi: 10.1016/j.jiac.2019.01.002. Epub 2019 Feb 2.
2
Impact of empirical treatment with antifungal agents on survival of patients with candidemia.抗真菌药物经验性治疗对念珠菌血症患者生存率的影响。
Rev Esp Quimioter. 2019 Feb;32(1):6-14. Epub 2018 Nov 30.
3
Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysis.根据当前药敏折点的不恰当抗真菌治疗对念珠菌血流感染死亡率的影响：一项回顾性分析
BMC Infect Dis. 2017 Dec 6;17(1):753. doi: 10.1186/s12879-017-2846-2.
4
Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal Medicine wards: A multicenter study.内科病房非中性粒细胞减少患者念珠菌血症危险因素评估：一项多中心研究。
Eur J Intern Med. 2017 Jun;41:33-38. doi: 10.1016/j.ejim.2017.03.005. Epub 2017 Mar 15.
5
Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance.氟康唑药敏性对念珠菌血症患者结局的影响：基于人群监测的数据。
Clin Microbiol Infect. 2017 Sep;23(9):672.e1-672.e11. doi: 10.1016/j.cmi.2017.01.014. Epub 2017 Jan 29.
6
Identification and Antifungal Susceptibility Testing of Species: A Comparison of Vitek-2 System with Conventional and Molecular Methods.菌种鉴定及药敏试验：Vitek-2系统与传统方法和分子方法的比较
J Glob Infect Dis. 2016 Oct-Dec;8(4):139-146. doi: 10.4103/0974-777X.192969.
7
Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.亚太地区侵袭性念珠菌属感染中念珠菌血症的流行病学及抗真菌药敏情况
Future Microbiol. 2016 Oct;11:1461-1477. doi: 10.2217/fmb-2016-0099. Epub 2016 Oct 18.
8
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.《念珠菌病管理临床实践指南：美国传染病学会2016年更新版》
Clin Infect Dis. 2016 Feb 15;62(4):e1-50. doi: 10.1093/cid/civ933. Epub 2015 Dec 16.
9
Clinical and epidemiological characteristics and risk factors for mortality in patients with candidemia in hospitals from Bogotá, Colombia.哥伦比亚波哥大医院念珠菌血症患者的临床和流行病学特征及死亡风险因素
Braz J Infect Dis. 2014 Nov-Dec;18(6):631-7. doi: 10.1016/j.bjid.2014.06.009. Epub 2014 Sep 1.
10
Impact of new antifungal breakpoints on antifungal resistance in Candida species.新型抗真菌药物折点对念珠菌属抗真菌药物耐药性的影响。
J Clin Microbiol. 2014 Mar;52(3):994-7. doi: 10.1128/JCM.03044-13. Epub 2014 Jan 8.
Zotero 插件